Johnson & Johnson TALVEY — Percent Change (as a percent) increased by 2.2% to 95.0% in Q3 2025 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
A positive percentage indicates accelerating growth, while a negative percentage suggests a slowdown in product adoption or market share loss.
This metric measures the period-over-period percentage growth or decline in net sales for the TALVEY product line. It pr...
Comparable to revenue growth rate disclosures for specific drug franchises or product lines across the biopharmaceutical industry.
jnj_segment_talvey_percent_change_as_a_percent| Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|
| Value | 83.6% | 93% | 95% |
| QoQ Change | — | +11.2% | +2.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.